Impact of tumour location and surgical approach on recurrence‐free and cancer‐specific survival analysis in patients with ureteric tumours
- 11 May 2012
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 110 (11b) , E514-E519
Abstract
Study Type – Therapy (case series) Level of Evidence 4 What's known on the subject? and What does the study add? Pathological stage, lymph node metastasis and tumour grade have been established as prognostic factors for upper‐tract urothelial carcinoma, but there are few studies to date assessing location within the ureter as a prognostic factor. There are also few studies comparing surgical approaches to radical nephroureterectomy (NU), partial ureterectomy and endoscopic resection (ENDO) with regard to oncological outcomes. This study did not find any prognostic significance for tumour location or surgical approach with regard to outcomes in patients with ureteric tumours. Although NU is the standard treatment for invasive ureteric tumours, partial ureterectomy and ENDO can safely be performed in selected patients. Despite the risk of a shorter time to recurrence, ENDO can be recommended in low grade, non‐invasive ureteric tumours but only with close, thorough surveillance practices. OBJECTIVE: To assess the impact of tumour location within the ureter and the impact of surgical approach on recurrence‐free survival (RFS) and cancer‐specific survival (CSS) with regard to ureteric tumours. PATIENTS AND METHODS: Data were retrospectively reviewed from 60 patients with isolated primary ureteric tumours, treated at a single tertiary referral centre. Patients were treated with radical nephroureterectomy (NU, n = 33), partial ureterectomy ( n = 17) or endoscopic resection (ENDO, n = 10). Kaplan–Meier curves were used for the analysis of RFS and CSS after surgery, stratified by tumour location and surgical approach. RESULTS: With a median follow‐up of 29 months, tumour location was not associated with disease recurrence ( P = 0.423). The ENDO group had shorter time to disease recurrence. There were no significant differences in the probability of CSS with regard to either tumour location or surgical approach ( P = 0.523 and P = 0.904, respectively). CONCLUSIONS: Tumour location or surgical approach were not significant predictors of oncological outcomes in patients with ureteric tumours. Although NU is standard treatment for invasive ureteric tumours, partial ureterectomy and ENDO can safely be performed in selected patients. Despite the risk of a shorter time to recurrence, ENDO can be recommended in low grade, non‐invasive ureteric tumours. All urothelium‐preserving approaches require thorough surveillance.Keywords
This publication has 29 references indexed in Scilit:
- Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: A population-based study of 2299 patientsEuropean Journal of Cancer, 2009
- What Is the Cost of Maintaining a Kidney in Upper-Tract Transitional-Cell Carcinoma? An Objective Analysis of Cost and SurvivalJournal of Endourology, 2009
- Lymphovascular Invasion Predicts Clinical Outcomes in Patients With Node-Negative Upper Tract Urothelial CarcinomaJournal of Clinical Oncology, 2009
- Conservative management in selected patients with upper tract urothelial carcinoma compares favourably with early radical surgeryBJU International, 2008
- Urothelial Carcinoma of the Upper Urinary Tract: Surgical Approach and Prognostic FactorsEuropean Urology, 2008
- Prognostic Value of Lymph Node Dissection in Patients with Muscle-Invasive Transitional Cell Carcinoma of the Upper Urinary TractEuropean Urology, 2008
- Imperative Indications for Conservative Management of Upper Tract Transitional Cell CarcinomaJournal of Urology, 2007
- Upper Urinary Tract Cancer: Location is Correlated with PrognosisEuropean Urology, 2005
- Conservative Elective Treatment of Upper Urinary Tract Tumors: A Multivariate Analysis of Prognostic Factors For Recurrence and ProgressionJournal of Urology, 2003
- IMPACT OF DIAGNOSTIC URETEROSCOPY ON LONG-TERM SURVIVAL IN PATIENTS WITH UPPER TRACT TRANSITIONAL CELL CARCINOMAJournal of Urology, 1999